, which is released from the side chain of phosphorylated amino acids upon collision-induced dissociation. Superscripted numbers in each mass spectrum refer to the detected charge state for each peptide in the negative ion mode. The mass spectrometry data shown here are not quantitative between the two samples. (B) BubR1 peptide sequences assigned to the phosphopeptides identified in the precursor ion scans. Sequences were confirmed, and the exact site of phosphorylation was determined by tandem mass spectrometry. The peptide 668-677 +P was found to be monophosphorylated on the two different sites shown. (C) Phosphorylation sites in human BubR1 occur on residues conserved among vertebrates. Red rectangles indicate the position of the BubR1 phosphorylation site in humans and the relative position of the same site in other species. Figure S2 . Verification of the specificity of BubR1 phosphoantibodies. (A) Mitotic lysates were treated and untreated with l protein phosphatase (PPase) and probed with the phosphoantibodies. (B) Mitotic (M) and asynchronous (A) HeLa lysates were probed with the indicated concentrations of pS670, pS1043 and BubR1 antibodies, and peptides. P-pep and pep denote phosphopeptides and nonphosphopeptides, respectively. (C) HeLa cells were stained for pS1043, BubR1, and DAPI. (D) HeLa cells were extracted, fixed, and costained with DAPI, BubR1, ACA, and pS670/pS1043 antibody + 300 nM nonphosphopeptide or 300 nM phosphopeptide. (E) Mitotic cells were released from a nocodazole arrest, and samples were collected every 30 min for 2.5 h. MG132 was added to one sample at the time of drug washout to prevent mitotic exit. Lysates were probed with affinity-purified BubR1 antibodies. Cyclin B1 was used to monitor activation of APC/C. PP2Ac serves as a loading control. (F) Cells were fixed first and stained with pS670 antibody to visualize the cytosolic pool of the antibody. Ana, anaphase; Ana A, early anaphase; Ana B, late anaphase; Int, interphase; Meta, metaphase; Pro, prophase; Prometa, prometaphase. Figure S3 . Phospho-BubR1 mutants do not disrupt Mad1 and CENP-E localization at kinetochores. (A) Cells depleted of BubR1 by siRNA were transfected with GST-wild type (WT) as well as GST-KD, GST-QA, and GST-QD mutants. Lysates were probed with BubR1 antibodies that detect both endogenous and GST/BubR1. CENP-F was used as a loading control. (B) Cells depleted of BubR1 by siRNA were transfected with GST-wild type, and GST-QA and GST-QD were fixed and stained for DAPI, GST, Mad1, and CENP-E. (C) HeLa cells transfected with BubR1 siRNA were injected with 33Flag BubR1
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RNAi S670A and S670D mutant constructs and stained for Flag, ACA, and DAPI. H2B/GFP was used to identify transfected cells. 
